Investors Alleging $51M Loss To Lead Pharma Co. Suit
A New York judge on Wednesday appointed two institutional investors to lead a proposed shareholder action alleging biopharma company Syneos Health lied about its booming business during the COVID-19 pandemic, saying...To view the full article, register now.
Already a subscriber? Click here to view full article